In two patients (Figure 7A and Figure 8) the peak of S100B occurred 14 days after the observed peak of IL-6 which might suggest that IL-6 reflects immune activation but may not be implicated in the local anticancer immune reaction within the cancer tissue. The gene discussed is IL6; the disease is cancer.